|
Baseline
|
6-month follow-up
|
p (baseline vs 6-month follow-up)
|
---|
All patients (n = 37)
|
IM (n = 18)
|
IA (n = 19)
|
All patients (n = 37)
|
IM (n = 18)
|
IA (n = 19)
|
All patients
|
IM
|
IA
|
---|
tcpO2 (mmHg)
|
16 ± 10
|
16 ± 10
|
17 ± 10
|
29 ± 14
|
30 ± 16
|
28 ± 12
|
<0.001
|
<0.001
|
<0.005
|
ABI
|
0.8 ± 0.3
|
0.8 ± 0.3
|
0.8 ± 0.3
|
0.9 ± 0.3
|
0.9 ± 0.2
|
0.9 ± 0.3
|
0.1
|
0.06
|
0.36
|
Pain scale (0–10)
|
4.4 ± 2.4
|
3.8 ± 2.1
|
5.0 ± 2.5
|
1.6 ± 1.6
|
1.2 ± 1.0
|
1.9 ± 1.9
|
<0.001
|
<0.001
|
<0.001
|
Rutherford category
|
5.0
|
5.0
|
5.0
|
4.0 ± 1.3
|
3.8 ± 1.3
|
4.2 ± 1.1
|
<0.001
|
<0.001
|
<0.005
|
-
ABI ankle-brachial index, BM-MNC bone marrow-derived mononuclear cell, IA intra-arterial, IM intramuscular, tcpO
2
transcutaneous oxygen pressure